Head and Neck Squamous Cell Carcinoma (HNSCC) Latest Advances

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer.

Journal: Science immunology

Published: April 10, 2026

Correlation of E-cadherin, vimentin, CD206, programmed cell death receptor 1, and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma.

Journal: The Journal of international medical research

Published: April 09, 2026

The Prognostic Value of SERPINE1 in Clinical Outcomes in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Technology in cancer research & treatment

Published: April 03, 2026

Transcriptomic atlas of premalignant oral squamous cell carcinoma in an aging mouse model reveals an enhanced immune response and dysregulation of head and neck tissue stem cells.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: April 02, 2026

Effect of Golgi membrane protein 1 on the proliferation, migration, and invasion of oral squamous cell carcinoma cells and its mechanism

Journal: Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology

Published: March 31, 2026

BPI26-017: Feasibility and Early Clinical Outcomes of Hypofractionated Concurrent Chemoradiation (55 Gy in 20 Fractions) for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Institutional Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

Correlations between regulatory T cells and the tumor immune microenvironment in head and neck squamous cell carcinoma

Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology

Published: March 31, 2026

HSR26-229: Efficacy and Safety of Immune Checkpoint Inhibitors Compared to Chemotherapy and Radiotherapy Alone in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Reconstructed Time-to-Event Data from Randomized Controlled Trials.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 26, 2026

Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.

Journal: Radiation research

Published: March 25, 2026

Head and Neck Squamous Cell Carcinoma (HNSCC) Latest Advances

Find the Latest Research About Head and Neck Squamous Cell Carcinoma (HNSCC)

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.

Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer.

Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer.

Correlation of E-cadherin, vimentin, CD206, programmed cell death receptor 1, and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma.

Correlation of E-cadherin, vimentin, CD206, programmed cell death receptor 1, and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma.

The Prognostic Value of SERPINE1 in Clinical Outcomes in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

The Prognostic Value of SERPINE1 in Clinical Outcomes in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Transcriptomic atlas of premalignant oral squamous cell carcinoma in an aging mouse model reveals an enhanced immune response and dysregulation of head and neck tissue stem cells.

Transcriptomic atlas of premalignant oral squamous cell carcinoma in an aging mouse model reveals an enhanced immune response and dysregulation of head and neck tissue stem cells.

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

Effect of Golgi membrane protein 1 on the proliferation, migration, and invasion of oral squamous cell carcinoma cells and its mechanism

Effect of Golgi membrane protein 1 on the proliferation, migration, and invasion of oral squamous cell carcinoma cells and its mechanism

BPI26-017: Feasibility and Early Clinical Outcomes of Hypofractionated Concurrent Chemoradiation (55 Gy in 20 Fractions) for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Institutional Study.

BPI26-017: Feasibility and Early Clinical Outcomes of Hypofractionated Concurrent Chemoradiation (55 Gy in 20 Fractions) for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Institutional Study.

Correlations between regulatory T cells and the tumor immune microenvironment in head and neck squamous cell carcinoma

Correlations between regulatory T cells and the tumor immune microenvironment in head and neck squamous cell carcinoma

HSR26-229: Efficacy and Safety of Immune Checkpoint Inhibitors Compared to Chemotherapy and Radiotherapy Alone in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Reconstructed Time-to-Event Data from Randomized Controlled Trials.

HSR26-229: Efficacy and Safety of Immune Checkpoint Inhibitors Compared to Chemotherapy and Radiotherapy Alone in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Reconstructed Time-to-Event Data from Randomized Controlled Trials.

Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.

Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.

Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.

Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.